We offer expert regulatory consulting and strategic support for companies, laboratories, and organisations involved in advancing in vitro biomarker testing – from research to routine patient care. Our services ensure regulatory compliance and align with the requirements of your target markets – whether that’s Switzerland, the EU, the USA, Brazil, or South Korea. We help accelerate market access and enable the introduction of innovative diagnostics while supporting established diagnostics that meet patient and healthcare needs.